Table 2.
Primary clinicopathologic diagnoses
| Proliferative GN, n=204 | Nonproliferative Glomerulopathies, n=123 | Paraprotein, n=49 | DN, n=75 | Vascular, n=54 | Tubulointerstitial, n=49 | Advanced, n=78 | Other, n=44 |
|---|---|---|---|---|---|---|---|
| IgA nephropathy (73) | Membranous nephropathy (47) | AL amyloid (21) | DN (75) | Vascular sclerosis (37) | AIN (14) | Secondary | TBM (15) |
| Lupus nephritis | Minimal change disease (24) | MIDD (15) | TMA (12) | ATN (14) | FSGS (40) | Normal (15) | |
| Class 2 (8) | Idiopathic FSGS (15) | AA amyloid (5) | APLS (2) | Chronic/active IN (6) | Advanced chronic changes (37) | Lymphoma infiltration (7) | |
| Class 3 (A or A/C) (14) | Lupus nephritis | Cast nephropathy (4) | Scleroderma (1) | Oxalate nephropathy (6) | Adenovirus (1) | Mild IFTA (7) | |
| Class 3+5 (A or A/C) (11) | Class 2+5 (1) | Immunotactoid GN (1) | CNI toxicity (1) | CIN (3) | |||
| Class 4 (A or A/C) (23) | Class 3 (C) (1) | Light-chain crystal tubulopathy (1) | Cholesterol emboli (1) | Granulomatous IN (3) | |||
| Class 4+5 (A or A/C) (9) | Class 4 (C) (5) | Light-chain proteinuria (1) | Phosphate nephropathy (2) | ||||
| Class 4+6 (A or A/C) (1) | Class 3 (C) +5 (1) | Multiple myeloma (1) | Tenofovir nephrotoxicity (1) | ||||
| ANCA (27) | Class 4 (C) +5 (1) | ||||||
| Immune complex GN (14) | Class 5 (23) | ||||||
| Postinfectious GN (3) | Class 6 (1) | ||||||
| Cryoglobulinemia (4) | Collapsing glomerulopathy (3) | ||||||
| PGNMID (2) | C1q nephropathy (1) | ||||||
| C3 GN (4) | Idiopathic nodular glomerulosclerosis (1) | ||||||
| HIV immune complex GN (1) | |||||||
| Fibrillary GN (3) | |||||||
| Hereditary nephritis (1) | |||||||
| Membranoproliferative GN (2) | |||||||
| Crescentic GN (3) |
Actual number of patients (n) in each category. DN, diabetic nephropathy; AL, amyloid light chain; AIN, acute interstitial nephritis; TBM, thin basement membrane; MIDD, monoclonal immunoglobulin deposition disease; TMA, thrombotic microangiopathy; ATN, acute tubular necrosis; AA, serum amyloid A protein; APLS, antiphospholipid syndrome; IN, interstitial nephritis; IFTA, interstitial fibrosis and tubular atrophy; CNI, calcineurin inhibitor toxicity; CIN, chronic interstitial nephritis; PGNMID, proliferative GN with monoclonal immunoglobulin deposits.